CASDIN CAPITAL, LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | BBOT | 282K | $3.27M |
 | VCYT | 276K | $9.49M |
 | HIMS | 230K | $13.05M |
 | RXRX | 165K | $806.78K |
 | CTNM | 148K | $1.74M |
 | GH | 100K | $6.25M |
 | INCY | 100K | $8.48M |
 | EXAS | 90K | $4.92M |
 | GLUE | 86K | $637.36K |
 | ALNY | 55K | $25.08M |
 | DNA | 36K | $532.07K |
 | UNH | 25K | $8.63M |
BridgeBio Oncology Therapeutics Inc.
BBOT
Shares Held
282K
Value
$3.27M
Veracyte, Inc.
VCYT
Shares Held
276K
Value
$9.49M
Hims & Hers Health, Inc.
HIMS
Shares Held
230K
Value
$13.05M
Recursion Pharmaceuticals, Inc.
RXRX
Shares Held
165K
Value
$806.78K
Contineum Therapeutics, Inc. Class A Common Stock
CTNM
Shares Held
148K
Value
$1.74M
Guardant Health, Inc.
GH
Shares Held
100K
Value
$6.25M
Incyte Corporation
INCY
Shares Held
100K
Value
$8.48M
Exact Sciences Corporation
EXAS
Shares Held
90K
Value
$4.92M
Monte Rosa Therapeutics, Inc.
GLUE
Shares Held
86K
Value
$637.36K
Alnylam Pharmaceuticals, Inc.
ALNY
Shares Held
55K
Value
$25.08M
Ginkgo Bioworks Holdings, Inc.
DNA
Shares Held
36K
Value
$532.07K
UnitedHealth Group Incorporated
UNH
Shares Held
25K
Value
$8.63M